Griffiths JB (1988), Cell products: an overview, In: Spier RE, Griffiths JB (Eds),
Animal Cell Biotechnology, Vol. 3, Academic Press, London, pp. 179–221.
Hayflick L, Moorhead PS (1961), The serial cultivation of human diploid cell strains,
Exp. Cell Res. 25:585–621.
Heath CA (2000), Cells for tissue engineering, Trends Biotechnol. 18:17–19.
Hot Drugs (2004), Nat. Rev. Drug Discov., Suppl. Vol. 3.
Hwang WS, Ryu YJ, Park JH, Park ES, Lee E, Koo, JM, Jeon HY, Lee BC, Kang SK,
Kim SJ, Ahn C, Hwang JH, Park KY, Cibelli JB, Moon SY (2004), Evidence of a
pluripotent human embryonic stem cell line derived from a cloned blastocyst,
Science 303:1669–1674.
Kohler G, Milstein C (1975), Continuous cultures of fused cells secreting antibody of
predefined specificity, Nature 256:495–497.
Laflamme MA, Murry CE (2005), Regenerating the heart, Nat. Biotechnol. 23:
845–856.
Land H, Parada LF, Weinberg RA (1983), Tumorigenic conversion of primary
fibroblasts requires at least two co-operating oncogenes, Nature 304:596–602.
MacDonald C (1990), Development of new cell lines for animal cell biotechnology,
CRC Crit. Rev. Biotechnol. 10:155–178.
Mayhall EA, Paffett-Lugassy N, Zon LI (2004), The clinical potential of stem cells,
Curr. Opin. Cell Biol. 16:713–720.
Merten O-W, Cruz PE, Rochette C, Geny-Fiamma C, Bouquet C, Gonc¸alves D,
Danos O, Carrondo MJT (2001), Comparison of different bioreactor systems for
the production of high titer retroviral vectors, Biotechnol. Prog. 17:326–335.
Monoclonal antibodies and therapies (2004), Supplement to Nature Publishing Group,
http://www.nature.com/focus/antibodies/index.html, accessed in February 2006.
Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBridge
OW, Leonard WJ (1993), Interleukin-2 receptor gamma chain mutation results in
X-linked severe combined immunodeficiency in humans, Cell 73:147–157.
Powers MJ, Janigian DM, Wack KE, Baker CS, Beer Stolz D, Griffith LG (2002),
Functional behavior of primary rat liver cells in a three-dimensional perfused
microarray bioreactor, Tissue Eng. 8:499–513.
Ruley HE (1983), Adenovirus early region 1A enables viral and cellular genes to
transform primary cell in culture, Nature 304:602–606.
Shah AC, Benos D, Gillespie GY, Markert JM (2003), Oncolytic viruses: clinical
applications as vectors for the treatment of malignant gliomas, J. Neurooncol.
65:203–226.
Spier RE (2000), History of animal cell technology, In: Spier RE (Ed.), Encyclopedia
of Cell Technology, John Wiley & Sons, New York, v. 2, pp. 853–872.
Walsh G (2004), Modern antibody based therapeutics, BioPharm. International,
December, 18–25.
Whalen, R.G. 1996. DNA vaccines for emerging infectious diseases: What if? Emerg.
Infect. Dis. 2: 168-175.
Witkowski JA (1979), Alexis Carrel and the mysticism of tissue culture. Med. Hist.
23:279–296.
12 Animal Cell Technology